败血症诊断市场规模、份额和成长分析（按技术、应用、产品、方法、病原体类型、检测类型、最终用户和地区）—2025-2032 年产业预测

2023 年败血症诊断市场规模价值 6.9 亿美元，预计将从 2024 年的 7.5 亿美元成长到 2032 年的 14.6 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.7%。

由于老年人和免疫力缺乏等高风险族群中感染疾病相关住院人数不断增加，败血症诊断市场已成为医疗保健领域的重要领域。多重检测和快速 PCR 检测等技术进步正在提高检测的速度和准确性，而监管措施正在推动败血症管理的改善。儘管具有这种潜在的增长，但由于特异性症状导致的败血症诊断的复杂性以及诊断测试成本的上升等挑战，限制了其在资源受限环境中的使用。此外，多样化的测试协议和标准化的需求可能会阻碍创新技术的采用。然而，在新生物标誌物的开发、快速检测解决方案、人工智慧和机器学习的整合以及协作研发工作中仍存在机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

败血症诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 血液培养技术

败血症诊断市场规模（按应用和复合年增长率）（2025-2032）

• 市场概况
• 医院
• 诊断中心

败血症诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 血培养基
• 检测试剂组
• 装置
• 软体

败血症诊断市场规模（依方法和复合年增长率） (2025-2032)

• 市场概况
• 常规诊断
• 自动诊断

败血症诊断市场规模（按病原体类型和复合年增长率）（2025-2032）

• 市场概况
• 细菌性败血症
  • 革兰氏阴性菌脓毒症
  • 革兰氏阳性细菌性脓毒症真菌性脓毒症
• 其他病原体类型

败血症诊断市场规模（按测试类型和复合年增长率） (2025-2032)

• 市场概况
• 实验室测试
• 就地检验

败血症诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院和专科诊所
• 病理学和参考实验室
• 研究部门
• 学术机构

败血症诊断市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• BioMerieux SA（France）
• Becton, Dickinson and Company（BD）（USA）
• Thermo Fisher Scientific, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（Beckman Coulter, Inc.）（USA）
• Bruker Corporation（USA）
• Abbott Laboratories, Inc.（USA）
• Cepheid（USA）
• Luminex Corporation（USA）
• T2 Biosystems, Inc.（USA）
• Siemens Healthineers（Germany）
• Qiagen NV（Netherlands）
• Immunexpress, Inc.（USA）
• Seegene Inc.（South Korea）
• Koninklijke Philips NV（Netherlands）
• GenMark Diagnostics（USA）
• Wolters Kluwer NV.（Netherlands）
• Epic Systems Corporation.（USA）
• McKesson Corporation.（USA）

结论和建议

Sepsis Diagnostics Market size was valued at USD 0.69 billion in 2023 and is poised to grow from USD 0.75 billion in 2024 to USD 1.46 billion by 2032, growing at a CAGR of 8.7% during the forecast period (2025-2032).

The sepsis diagnostics market is a crucial segment of the healthcare sector, driven by rising infection-related hospitalizations among high-risk populations, including the elderly and immunocompromised individuals. Technological advancements such as multiplex assays and rapid PCR tests are enhancing detection speed and accuracy, while regulatory initiatives are fostering improved sepsis management practices. Despite this growth potential, challenges such as high diagnostic test costs limit accessibility in resource-constrained settings, alongside the complexity of sepsis diagnosis due to its non-specific symptoms. Additionally, varying testing protocols and the need for standardization may hinder the adoption of innovative technologies. However, opportunities exist in the development of new biomarkers, rapid testing solutions, and the integration of AI and machine learning, along with collaborative research and development efforts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sepsis Diagnostics Market Segments Analysis

Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests and Point-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is significantly driven by the rising awareness and training initiatives aimed at healthcare professionals, emphasizing the importance of early sepsis detection and management. This growing focus is leading to a higher uptake of diagnostic tests and related services. Additionally, there has been a surge in public education campaigns highlighting the symptoms and signs of sepsis, which encourages individuals to seek timely medical attention. As a result, this proactive approach not only fosters prompt diagnosis but also enhances testing frequencies, further stimulating the overall growth of the Sepsis Diagnostics market.

Restraints in the Sepsis Diagnostics Market

The Sepsis Diagnostics market faces significant challenges due to the diverse and non-specific signs and symptoms associated with sepsis, which complicate early diagnosis. This complexity can lead to delays in treatment or misdiagnosis, undermining the effectiveness of diagnostic tools. Furthermore, accurate sepsis diagnosis often requires a combination of tests, which adds to the complexity and extends the turnaround time for results. This protracted process can hamper patient outcomes and diminish the perceived value of diagnostic solutions, ultimately restraining the growth and development of the Sepsis Diagnostics market. Addressing these issues is crucial for improving diagnostic efficiency and market expansion.

Market Trends of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is witnessing a significant trend towards the adoption of advanced molecular diagnostic techniques, particularly next-generation sequencing (NGS) and polymerase chain reaction (PCR). These methodologies are revolutionizing pathogen detection by providing accurate and rapid results, drastically reducing the time for diagnosis compared to traditional culture methods. This shift is critical in sepsis management, as early intervention greatly enhances patient outcomes. As healthcare providers increasingly prioritize timely diagnostics, the demand for these innovative technologies is surging, positioning them as essential components in combating sepsis and driving overall market growth. The focus on precision medicine further amplifies this trend, promising enhanced efficacy in treatment protocols.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Sepsis Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Blood Culture Technology

Global Sepsis Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostics Centres

Global Sepsis Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Blood Culture Media
• Assays and Reagent Kits
• Instruments
• Software

Global Sepsis Diagnostics Market Size by Method & CAGR (2025-2032)

• Market Overview
• Conventional Diagnostics
• Automated Diagnostics

Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2025-2032)

• Market Overview
• Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis Fungal Sepsis
• Other Pathogen Types

Global Sepsis Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Laboratory Tests
• Point-Of-Care Tests

Global Sepsis Diagnostics Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals And Speciality Clinics
• Pathology and Reference Laboratories
• Research Laboratories
• Academic Institute

Global Sepsis Diagnostics Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • US
  • Canada
• Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Beckman Coulter, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunexpress, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wolters Kluwer NV. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations